These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7342049

  • 1. [Evaluation of Euphylline-retard based on the measurement of theophylline concentration in the blood serum and spirometric parameters].
    Pietruszewska E, Droszcz W, Wrońska J, Kowalski J.
    Pneumonol Pol; 1981 Nov; 49(11):783-9. PubMed ID: 7342049
    [No Abstract] [Full Text] [Related]

  • 2. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN, Bogovskiĭ BP, Gavrilenko LN, Kushkenbaeva BE, Kukes VG.
    Ter Arkh; 1990 Nov; 62(9):22-5. PubMed ID: 2281401
    [No Abstract] [Full Text] [Related]

  • 3. [Serum theophylline steady-state levels: comparative study of 2 retard preparations].
    Kaukel E, Koppermann G.
    Prax Klin Pneumol; 1983 Mar; 37(3):109-12. PubMed ID: 6856560
    [No Abstract] [Full Text] [Related]

  • 4. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S, Vrabec B, Francetić I, Bakran I.
    Lijec Vjesn; 1989 Mar; 111(9-10):341-3. PubMed ID: 2633012
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H.
    Wien Med Wochenschr; 1983 Aug 31; 133(15-16):403-8. PubMed ID: 6636797
    [Abstract] [Full Text] [Related]

  • 6. [The clinical pharmacology of a new Soviet preparation theopek].
    Kukes VG, Tsoĭ AN, Stefadu EG, Gneushev ET, Kniazev RP, Gavrilenko LN.
    Ter Arkh; 1990 Aug 31; 62(1):67-70. PubMed ID: 2333622
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of serum theophylline levels with plain and slow-release aminophylline in patient with airway obstruction.
    Muittari A, Allonen H.
    J Int Med Res; 1981 Aug 31; 9(5):378-80. PubMed ID: 7028535
    [No Abstract] [Full Text] [Related]

  • 8. Elevated serum theophylline concentration following cessation of erythromycin treatment.
    Wiggins J, Arbab O, Ayres JG, Skinner C.
    Eur J Respir Dis; 1986 Apr 31; 68(4):298-300. PubMed ID: 3732425
    [No Abstract] [Full Text] [Related]

  • 9. [Serum levels and spirometric response with sustained release theophylline].
    Otero MJ, Barrueco M, Mariño EL, Gómez F, de Portugal J, Domínguez-Gil A.
    Med Clin (Barc); 1985 Jan 19; 84(2):51-3. PubMed ID: 3974347
    [No Abstract] [Full Text] [Related]

  • 10. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
    Jenkins PF, White JP, Jariwalla AJ, Anderson G, Campbell IA.
    Br J Dis Chest; 1982 Jan 19; 76(1):57-60. PubMed ID: 7037034
    [Abstract] [Full Text] [Related]

  • 11. [The pharmacodynamics of theophylline (euphylline)].
    Tsoĭ AN, Bogovskiĭ BP, Saprygina TV, Kniazev RM, Titova EV, Kukes VG.
    Ter Arkh; 1993 Jan 19; 65(8):36-40. PubMed ID: 8211799
    [Abstract] [Full Text] [Related]

  • 12. Comparative effect of theophylline and aminophylline on theophylline blood concentrations and peripheral blood eosinophils in patients with asthma.
    Kato M, Tatsuta H, Okada K, Sakamoto K, Morita H.
    Drugs Exp Clin Res; 2001 Jan 19; 27(2):83-8. PubMed ID: 11392058
    [Abstract] [Full Text] [Related]

  • 13. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B, Sehrt I, Iwainsky H.
    Z Erkr Atmungsorgane; 1984 Jan 19; 162(1):3-10. PubMed ID: 6719957
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of the effectiveness of aminophylline in treating bronchial asthma and spastic bronchitis].
    Chyrek-Borowska S, Szymański W, Niklińska B, Obrzut D, Michalska I.
    Pol Tyg Lek; 1984 Jan 19; 43(42-43):1377-9. PubMed ID: 3075278
    [No Abstract] [Full Text] [Related]

  • 15. [Theophylline concentration in the blood of children with persistently recurring bronchial asthma].
    Gusel' VA, Zisel'son AD, Verbov VN, Gorshkova IuG.
    Farmakol Toksikol; 1986 Jan 19; 49(5):29-31. PubMed ID: 3770170
    [Abstract] [Full Text] [Related]

  • 16. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T.
    Int J Clin Pharmacol Ther; 1994 Nov 19; 32(11):625-31. PubMed ID: 7874380
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of circadian variation in serum theophylline levels in the sustained-release theophylline treatment of chronic asthma].
    Watanabe A, Urata C, Nomoto H, Mizobe M, Abe Y, Mano K, Miyamato Y, Sano Y.
    Arerugi; 1986 Jul 19; 35(7):447-54. PubMed ID: 3778214
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
    Eitner L, Wettengel R, Schnitker J.
    Prax Klin Pneumol; 1983 Jun 19; 37(6):236-42. PubMed ID: 6889277
    [No Abstract] [Full Text] [Related]

  • 19. [Monitoring serum concentrations of theophylline during aminophylline infusion therapy].
    Prazáková J, Vondra V.
    Cas Lek Cesk; 1985 Oct 25; 124(43):1332-5. PubMed ID: 4084951
    [No Abstract] [Full Text] [Related]

  • 20. Blood levels following oral administration of theophylline preparations.
    Jackson RH, Garrido R, Silverman HI, Salem H.
    Ann Allergy; 1973 Sep 25; 31(9):413-9. PubMed ID: 4725597
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.